Learning Study: Improving Vision in Adults With Macular Degeneration
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04762368 |
|
Recruitment Status :
Recruiting
First Posted : February 21, 2021
Last Update Posted : June 29, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this study is to test whether a kind of brain stimulation called anodal transcranial direct current stimulation (a-tDCS) can be combined with perceptual learning to improve the ability of people with age-related macular degeneration (AMD) or juvenile macular degeneration (JMD) to read words presented to them on a computer screen better than if perceptual learning alone were used.
In addition, secondary measures of visual acuity will also be examined to determine whether brain stimulation can allow patients to resolve finer details of an image. The proposed treatment is the application of a-tDCS onto the participant's head, with brain stimulation aimed at Primary Visual Cortex toward the occipital pole, while patients undergo six separate sessions of training. The investigators will test the ability of participants to read words before the start of the training sessions (pre test) and after the completion of all training sessions (post test). This is a between-subjects design, and half of the participants will receive true stimulation, and the other half will receive sham stimulation. The difference between the pre and post tests when receiving active stimulation will be compared to the difference when receiving sham stimulation, because the sham stimulation is not expected to influence reading beyond a placebo. The aim of the study is to examine the potential of concurrent brain stimulation and perceptual learning as an effective treatment for macular degeneration that may be used in conjunction with more traditional eye-based interventions. The investigators hypothesize that the brain stimulation will enable higher performance in the reading task after and secondary measures after perceptual training due to an increase in the cortical excitability of the stimulated brain cells.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Macular Degeneration | Device: Active anodal tDCS Device: Sham anodal tDCS | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 30 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Group A: 6 training sessions with active brain stimulation and perceptual training Group B: 6 training sessions with sham brain stimulation and perceptual training |
| Masking: | Double (Participant, Investigator) |
| Masking Description: | The participant and the researcher will be blind to which group any given participant is assigned to. |
| Primary Purpose: | Treatment |
| Official Title: | Improving Vision in Adults With Macular Degeneration, Study 2: The Effect of Concurrent Perceptual Learning and Brain Stimulation |
| Actual Study Start Date : | February 13, 2021 |
| Estimated Primary Completion Date : | February 2022 |
| Estimated Study Completion Date : | February 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Active + Training
Participants in this arm will be exposed to active stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.
|
Device: Active anodal tDCS
a weak electric current is applied to the head through electrodes to affect the cortical excitability of the targeted cells in the brain. |
|
Sham Comparator: Sham + Training
Participants in this arm will be exposed to sham stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.
|
Device: Sham anodal tDCS
The tDCS machine will be used as in active stimulation, except the electrical current will not be applied. |
- Change in Rapid Serial Visual Presentation (RSVP) Reading performance before and right after training. [ Time Frame: The pre test and post test will take roughly 1 hour to complete, and they will be roughly 4-7 weeks apart. ]Behavioral Measure - Participants will verbally read words presented on a computer. A variety of speeds and sizes will be presented, so that an accurate measure of the maximum reading speed, and the smallest text size readable at the maximum reading speed can be calculated. The maximum reading speed and smallest text size will be measured before and after training. The outcome measures are the change in these reading measurements from pre test to post test.
- Change in Rapid Serial Visual Presentation (RSVP) Reading performance 30 days after training [ Time Frame: The test will take roughly 1 hour to complete, and they will be roughly 7-10 weeks apart. ]Behavioral Measure - Participants will verbally read words presented on a computer. A variety of speeds and sizes will be presented, so that an accurate measure of the maximum reading speed, and the smallest text size readable at the maximum reading speed can be calculated. The maximum reading speed and smallest text size will be measured before and after training. The outcome measures are the change in these reading measurements from pre test to the 30 day follow up.
- Change in Uncrowded Visual Acuity before and just after training [ Time Frame: The pre test and post test will take roughly 5 minutes to complete, and they will be roughly 4-7 weeks apart. ]Visual acuity as measured by participants indicating the orientation of the gap present in a Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html . The outcome measure is the change in performance from pre test to the post test
- Change in Uncrowded Visual Acuity before and 30 days after training [ Time Frame: The pre test and post test will take roughly 5 minutes to complete, and they will be roughly 7 to 10 weeks apart. ]Visual acuity as measured by participants indicating the orientation of the gap present in a Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html . The outcome measure is the change in performance from pre test to the 30 day follow up.
- Change in Crowded Visual Acuity before and just after training [ Time Frame: The tests will take roughly 5 minutes to complete, and they will be roughly 4 - 7 weeks apart. ]Visual acuity as measured by participants indicating the orientation of the gap present in a Crowded (Ring) Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html . The outcome measure is the change in performance from pre test to post test.
- Change in Crowded Visual Acuity before and 30 days after training [ Time Frame: The tests will take roughly 5 minutes to complete, and they will be roughly 7 - 10 weeks apart. ]Visual acuity as measured by participants indicating the orientation of the gap present in a Crowded (Ring) Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html . The outcome measure is the change in performance from pre test to the 30 day follow up.
- Change in Contrast Sensitivity before and just after training [ Time Frame: The tests will take roughly 5 minutes to complete, and they will be roughly 4 - 7 weeks apart. ]Contrast sensitivity as measured by participants indicating the orientation of the gap present in a Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html . The outcome measure is the change in performance from pre test to the post test.
- Change in Contrast Sensitivity before and 30 days after training [ Time Frame: The tests will take roughly 5 minutes to complete, and they will be roughly 7-10 weeks apart. ]Contrast sensitivity as measured by participants indicating the orientation of the gap present in a Landolt C stimulus using the freely available FrACT software https://michaelbach.de/fract/index.html . The outcome measure is the change in performance from pre test to the 30 day follow up.
- Change in Temporal Visual Span before and just after training [ Time Frame: The test will take roughly 1.5 hours to complete, and they will be roughly 5-8 weeks apart ]Three unrelated Chinese characters will appear at the centre of a monitor for a range of exposure times. Participants will be asked to recognize all three characters in a correct order. Both horizontal and vertical presentation will be assessed. The outcome measures are the changes in time for recognizing the characters from pre test to the post test.
- Change in Spatial Visual Span before and just after training [ Time Frame: The test will take roughly 1.5 hours to complete, and they will be roughly 5-8 weeks apart. ]Three unrelated Chinese character will appear at different character positions for a fixed exposure time, while participants will be asked to keep fixation at the centre but recognize all three characters in a correct order. Both horizontal and vertical presentation will be assessed. The outcome measures are the changes in the size of the spatial visual span from pre test to the post.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosis of AMD (age 60+) or JMD (current age 18+).
- Visual acuity (VA); between 6/9-6/96 in the better eye
- Best-corrected near visual acuity of 4.0M at 40 cm or better in the better eye
- Stable vision in previous 3 months (patient report)
- Central vision loss
Exclusion Criteria:
- Diagnosed dementia.
- Not fluent in reading English (Waterloo) or Chinese characters (Hong Kong).
- Any ocular surgery (including anti-vegF injections) within the duration of the study, except for: A. Chronic and continuous injections for at least 1 year. B. Injections stopped at least 2 months before participation. C. Injections in the untested eye
- Ocular pathology other than JMD or AMD that can significantly reduce central vision. Example: mild cataract of grade 2 or below is acceptable
- Severe hearing impairment.
- Contraindications for brain stimulation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04762368
| Contact: Ben Thompson, PhD | 15198884567 ext 39398 | ben.thompson@uwaterloo.ca | |
| Contact: Andrew E Silva, PhD | a8silva@uwaterloo.ca |
| Canada, Ontario | |
| University of Waterloo | Active, not recruiting |
| Waterloo, Ontario, Canada, N2L 3G1 | |
| Hong Kong | |
| The Hong Kong Polytechnic University | Recruiting |
| Hung Hom, Kowloon, Hong Kong | |
| Contact: Allen Cheong, PhD allen.my.cheong@polyu.edu.hk | |
| Principal Investigator: | Ben Thompson, PhD | University of Waterloo |
| Responsible Party: | Ben Thompson, Professor; Associate Director for Research, University of Waterloo |
| ClinicalTrials.gov Identifier: | NCT04762368 |
| Other Study ID Numbers: |
VSBrainStim2 |
| First Posted: | February 21, 2021 Key Record Dates |
| Last Update Posted: | June 29, 2021 |
| Last Verified: | June 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | IDP that underlie results in a publication will be available after deidentification upon reasonable request to the research team. |
| Supporting Materials: |
Analytic Code |
| Time Frame: | IDP will be available upon a publication, and no more than 9 months after the publication. |
| Access Criteria: | IDP will be shared to researchers who provide a methodologically sound proposal. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Macular Degeneration Brain Stimulation Psychophysics Reading tDCS |
RSVP Visual Acuity Uncrowded Visual Acuity Crowded Visual Acuity Contrast Sensitivity |
|
Macular Degeneration Retinal Degeneration Retinal Diseases Eye Diseases |

